In-vitro Diagnostics Market - by Product Type (Instruments and Reagents & Kits), by Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis, Urinalysis, and Others), by Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Disorders, and Others), by End User (Hospital, Pathology Laboratories, Point-of-Care Diagnostics, Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast 2018 - 2026

  • Published On : Jul 2019 |
  • Pages : 262 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Global In-Vitro Diagnostics Market – For Cancer Management

In-vitro diagnostics (IVD) play a major role in advanced healthcare, as they provide vital information about an individual or patient after a sequence of tests. These are diagnostic tools, which act as precursors to any treatment.

The global in-vitro diagnostics market size was valued at US$ 60,274.1 million in 2017, and is expected to exhibit a CAGR of 4.6% over the forecast period (2018–2026).

Figure 1. Global In-Vitro Diagnostics Market Value (US$ Mn), by Region, 2018

In-vitro Diagnostics (IVD)  | Coherent Market Insights

                                                                     Source: Coherent Market Insights Analysis (2019)

Increasing global prevalence of cancer and autoimmune diseases is expected to propel the market growth

Rising prevalence of cancer and autoimmune diseases is expected to drive the global in-vitro diagnostics market. According to the American Diabetes Association 2016, an estimated 29.1 million Americans, contributing a total 9.3% of the population, had severe Type II diabetes, while around 1.25 million American children and adults having type 1 diabetes. Similarly,  according to the Multiple Sclerosis Foundation, 2017, multiple sclerosis autoimmune condition affects 2.5 million people with the global incidence of around 7 cases per 100,000 people per year.

Rising strategic acquisition and collaboration by market players for expanding their offering in the market is expected to bolster the market growth. For instance, in January 2017, Qiagen N.V. acquired Omicsoft Corporation to expand its bioinformatics portfolio. The acquisition will add Qiagen with additional features to manage, analyze, and share both primary data and analyzed results. Similarly, in July 2018, Arkray, Inc. partnered with Beckman Coulter, a company that manufactures biomedical testing devices, for launching the product, iQ Urinanalysis Workcell. It is a combination of products from both the companies and the commercialization of this product was done through Beckman Coulter.

Figure 2. Global In-Vitro Diagnostics Market Share (%), by Application, 2018 and 2026

                    In-vitro Diagnostics (IVD)  | Coherent Market Insights                 

Source: Coherent Market Insights Analysis (2019)

Increasing product approvals and product launches in the North America are expected to bolster the market growth

North America holds dominant position in the global in-vitro diagnostics market, owing to increasing product approvals by regulatory authorities. For instance, in 2016, Abbott Laboratories’ ZIKA molecular diagnostics test received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA). Furthermore, in 2017, bioMérieux, an in-vitro diagnostics manufacturer, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for VITEK MS, its MALDI-TOF1 mass spectrometry system for rapid pathogen identification, and for expanded identification of mycobacteria, Nocardia, and molds.

Increasing product launches in the region is the major factor expected to propel the market growth. For instance, in May 2018, Abbott Laboratories launched its Afinion 2 analyzer in the U.S., the newest generation of the Afinion test system. The Afinion 2 analyzer is a compact rapid, multi-assay platform that streamlines and simplifies the delivery of actionable, accurate measurements of hemoglobin A1c (HbA1c), and albumin to creatinine ratio (ACR) results at the point of care.

Moreover, support from regulatory authorities as well as other government organizations is further expected to support growth of the North America in-vitro diagnostics market over the forecast period. For instance in 2017, United Nations Children’s Fund (UNICEF) announced request for proposal for sustained supply of Zika virus point-of-care diagnostics during 2017 through 2019.

Key Players

Major players operating in the global in-vitro diagnostics market include Siemens Healthineers, Sysmex Corporation, Bio-Rad Laboratories, bioMérieux S.A., Becton Dickinson, and Company, Danaher Corporation, Abbott Laboratories, F. Hoffmann-la Roche Ltd, QIAGEN N.V., Arkray, Inc., Nittobo Medical Co., Ltd., Medical & Biological Laboratories Co., Ltd., Miraca Holdings Inc., and Mizuho Medy Co., Ltd.

In-vitro diagnostics is used as a diagnostic tool by clinicians for faster diagnosis and to ensure timely treatment for patients. According to the U.S. FDA, in-vitro diagnostic products are those reagents, instruments, and systems intended for use in diagnosis of disease or other conditions, including determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequela. Such products are intended for use in the collection, preparation, and examination of specimens taken from the human body.

Market Dynamics

Increasing product approval by market players is a major factor driving global in-vitro diagnostics market growth. For instance, in 2017, Bio-Rad Laboratories announced the U.S. Food and Drug Administration (FDA) clearance of BioPlex 2200 Syphilis Total and RPR Assay, which is a novel one-step universal testing method based on automated Treponemal/ non-Treponemal dual assay to aid in the syphilis infection.

Furthermore, inorganic strategies adopted by key players for enhancing their distribution network and offering best products in the market is expected to drive the market growth.  For instance, in January 2018, Atomo Diagnostics and Access Bio partnered to expand their coverage in regions across Africa, South East Asia, and South America. The collaboration aims to access HIV infected population in these regions to market HIV rapid testing products.

Key features of the study:

  • This report provides in-depth analysis of the global in-vitro diagnostics market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2018–2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global in-vitro diagnostics market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Siemens Healthineers, Sysmex Corporation, Bio-Rad Laboratories, bioMérieux S.A., Becton Dickinson, and Company, Danaher Corporation, Abbott Laboratories, F. Hoffmann-la Roche Ltd, QIAGEN N.V., Arkray, Inc., Nittobo Medical Co., Ltd., Medical & Biological Laboratories Co., Ltd., Miraca Holdings Inc., and Mizuho Medy Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global in-vitro diagnostics market  report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global in-vitro diagnostics market

Detailed Segmentation:

  • Global In-Vitro Diagnostics Market, By Product Type:
    • Instruments
    • Reagents & Kits
      • Blocking Buffers     
      • Proteins
      • Secondary Antibodies 
      • Substrates 
      • Others
  • Global In-Vitro Diagnostics Market, By Technology:
    • Immunoassay
    • Clinical Chemistry
    • Molecular Diagnostics
    • Microbiology
    • Hematology
    • Coagulation & Hemostasis
    • Urinalysis
    • Others
  • Global In-Vitro Diagnostics Market, By Application:
    • Infectious Diseases
    • Diabetes
    • Oncology
    • Cardiology
    • Nephrology
    • Autoimmune Disorders
    • Others
  • Global In-Vitro Diagnostics Market, By End User:
    • Hospital
    • Pathology Laboratories
    • Point-of-Care Diagnostics
    • Research Institutes
    • Others
  • Global In-Vitro Diagnostics Market, By Region:
    • North America
      • By Product Type:
        • Instruments
        • Reagents & Kits
          • Blocking Buffers
          • Proteins
          • Secondary Antibodies
          • Substrates
          • Others
      • By Technology:
        • Immunoassay
        • Clinical Chemistry
        • Molecular Diagnostics
        • Microbiology
        • Hematology
        • Coagulation & Hemostasis
        • Urinalysis
        • Others
      • By Application:
        • Infectious Diseases
        • Diabetes
        • Oncology
        • Cardiology
        • Nephrology
        • Autoimmune Disorders
        • Others
      • By End User:
        • Hospital
        • Pathology Laboratories
        • Point-of-Care Diagnostics
        • Research Institutes
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Instruments
        • Reagents & Kits
          • Blocking Buffers
          • Proteins
          • Secondary Antibodies
          • Substrates
          • Others
      • By Technology:
        • Immunoassay
        • Clinical Chemistry
        • Molecular Diagnostics
        • Microbiology
        • Hematology
        • Coagulation & Hemostasis
        • Urinalysis
        • Others
      • By Application:
        • Infectious Diseases
        • Diabetes
        • Oncology
        • Cardiology
        • Nephrology
        • Autoimmune Disorders
        • Others
      • By End User:
        • Hospital
        • Pathology Laboratories
        • Point-of-Care Diagnostics
        • Research Institutes
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Instruments
        • Reagents & Kits
          • Blocking Buffers
          • Proteins
          • Secondary Antibodies
          • Substrates
          • Others
      • By Technology:
        • Immunoassay
        • Clinical Chemistry
        • Molecular Diagnostics
        • Microbiology
        • Hematology
        • Coagulation & Hemostasis
        • Urinalysis
        • Others
      • By Application:
        • Infectious Diseases
        • Diabetes
        • Oncology
        • Cardiology
        • Nephrology
        • Autoimmune Disorders
        • Others
      • By End User:
        • Hospital
        • Pathology Laboratories
        • Point-of-Care Diagnostics
        • Research Institutes
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Instruments
        • Reagents & Kits
          • Blocking Buffers
          • Proteins
          • Secondary Antibodies
          • Substrates
          • Others
      • By Technology:
        • Immunoassay
        • Clinical Chemistry
        • Molecular Diagnostics
        • Microbiology
        • Hematology
        • Coagulation & Hemostasis
        • Urinalysis
        • Others
      • By Application:
        • Infectious Diseases
        • Diabetes
        • Oncology
        • Cardiology
        • Nephrology
        • Autoimmune Disorders
        • Others
      • By End User:
        • Hospital
        • Pathology Laboratories
        • Point-of-Care Diagnostics
        • Research Institutes
        • Others
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Instruments
        • Reagents & Kits
          • Blocking Buffers
          • Proteins
          • Secondary Antibodies
          • Substrates
          • Others
      • By Technology:
        • Immunoassay
        • Clinical Chemistry
        • Molecular Diagnostics
        • Microbiology
        • Hematology
        • Coagulation & Hemostasis
        • Urinalysis
        • Others
      • By Application:
        • Infectious Diseases
        • Diabetes
        • Oncology
        • Cardiology
        • Nephrology
        • Autoimmune Disorders
        • Others
      • By End User:
        • Hospital
        • Pathology Laboratories
        • Point-of-Care Diagnostics
        • Research Institutes
        • Others
      • By Country/Region:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Instruments
        • Reagents & Kits
          • Blocking Buffers
          • Proteins
          • Secondary Antibodies
          • Substrates
          • Others
      • By Technology:
        • Immunoassay
        • Clinical Chemistry
        • Molecular Diagnostics
        • Microbiology
        • Hematology
        • Coagulation & Hemostasis
        • Urinalysis
        • Others
      • By Application:
        • Infectious Diseases
        • Diabetes
        • Oncology
        • Cardiology
        • Nephrology
        • Autoimmune Disorders
        • Others
      • By End User:
        • Hospital
        • Pathology Laboratories
        • Point-of-Care Diagnostics
        • Research Institutes
        • Others
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Siemens Healthineers*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Sysmex Corporation
    • Bio-Rad Laboratories
    • BioMérieux S.A.
    • Becton Dickinson, and Company
    • Danaher Corporation
    • Abbott Laboratories
    • F. Hoffmann-la Roche Ltd
    • QIAGEN N.V.
    • Arkray, Inc.
    • Nittobo Medical Co., Ltd.
    • Medical & Biological Laboratories Co., Ltd.
    • Miraca Holdings Inc.
    • Mizuho Medy Co., Ltd.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Technology
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Merger and Acquisition Scenario
    • Key Highlights
    • PEST Analysis
  4. Global In-Vitro Diagnostics Market, By Product Type, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Instruments
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Reagents & Kits
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
        • Blocking Buffers
        • Proteins
        • Secondary Antibodies
        • Substrates
        • Others
  5. Global In-Vitro Diagnostics Market, By Technology, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Immunoassay
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Clinical Chemistry
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Molecular Diagnostics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Microbiology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Hematology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Coagulation & Hemostasis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Urinalysis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  6. Global In-Vitro Diagnostics Market, By Application, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Infectious Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Diabetes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Oncology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Cardiology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Nephrology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Autoimmune Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  7. Global In-Vitro Diagnostics Market , By End User, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Hospital
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Pathology Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Point-of-Care Diagnostics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Research Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  8. Global In-Vitro Diagnostics Market , By Region, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • Germany
        • U.K.
        • France        
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Company Profiles
      • Siemens Healthineers
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Sysmex Corporation
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bio-Rad Laboratories
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • bioMérieux S.A.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      •  Becton Dickinson, and Company
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Danaher Corporation
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Abbott Laboratories
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • F. Hoffmann-la Roche Ltd
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • QIAGEN N.V.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Arkray, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Nittobo Medical Co., Ltd.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Medical & Biological Laboratories Co., Ltd.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies  
      • Miraca Holdings Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Mizuho Medy Co., Ltd.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 36 market data tables and 25 figures on "In-Vitro Diagnostics Market - Global forecast to 2026”.

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.